Uma Mahadevan, MD

About Uma Mahadevan, MD

Uma Mahadevan, MD, is the Lynne and Marc Benioff Professor of Gastroenterology, Director of the Colitis and Crohn’s Disease Center, and Director of the Advanced IBD Fellowship at the University of California San Francisco. She completed a medical degree at the State University of New York in Brooklyn, residency in internal medicine at Mount Sinai Medical Center in New York, fellowship in gastroenterology at UCSF, and advanced fellowship in IBD at the Mayo Clinic, Rochester, Minnesota. For her exceptional work in pregnancy and drug safety and her mentoring of GI fellows and junior faculty, she received the AGA 2022 Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Research Mentor Award and the 2022 Sherman Prize.

Dr. Mahadevan is a fellow of the American Gastroenterological Association, for whom she is on the United Programming Committee, was Chair for the IMIBD Section, Chair of the AGA National IBD Parenthood initiative and Director (2023), and Co-Director (2022, 2017) of the AGA Postgraduate Course. She is a Fellow of the American College of Gastroenterology and served on the Educational Affairs Committee and as a member of the Advanced IBD Fellow Curriculum Committee. She is an inaugural councilor at the ASGE Artificial Intelligence Institute for Gastroenterology. She was Chair of the Crohn’s & Colitis Foundation Clinical Research Grants committee, a member of the National Scientific Advisory Committee and Taskforce on Women in IBD, and co-chair of the annual Crohn’s Colitis Congress (2020). Dr. Mahadevan is a member of the International Organization of IBD (IOIBD) for which she served on the nominating committee.

Dr. Mahadevan is a global expert on the management of pregnancy and drug safety in the patient with IBD. She chaired the Global Consensus on Management of Pregnancy in IBD (2025) and the joint AGA, Society of Maternal Fetal Medicine Clinical Care Pathway on the Management of IBD in Pregnancy (2019). The Global Consensus was jointly published in 6 international GI journals simultaneously. She is interested in diet and IBD and has an ongoing original study in this area. Her current projects include a national prospective registry of pregnancy outcomes and drug safety in women with IBD on immunosuppressive and biologic medications (PIANO) and a clinical trial on the impact of nutritional interventions in the management of IBD (SEAMUS). She has an interest in digital health and led the transition of the GI Division to telemedicine at the start of the pandemic in March 2020, developed an IBD Chatbot with the Center for Digital Health and Innovation at UCSF, and the IBD Smartnote. Dr. Mahadevan has served on many prestigious journals, including special section editor for Gastroenterology. Dr. Mahadevan is proud to have mentored several Advanced IBD Fellows who now hold key roles in IBD Centers around the United States.